Dr. Mohammed Ibrahim, MD

Dr. Ibrahim practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Ibrahim's NPI, 1891701082, was assigned on July 31, 2006. Dr. Ibrahim holds Michigan license 4301081380.

Dr. Ibrahim's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Ibrahim's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Ibrahim is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Ibrahim to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ibrahim practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ibrahim's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ibrahim is licensed in Michigan.

CMS data shows 72,000 Medicare services from Dr. Ibrahim across 49 procedure codes in 2024, for 672 Medicare patients. Medicare paid $990,743 for them.

CMS counts 672 Medicare patients who saw Dr. Ibrahim in 2024. The largest group is 65 to 74, with 261 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ibrahim's median patient age at 70, with 63% women.

In 2024, Dr. Ibrahim wrote 1,090 Medicare Part D claims for 247 patients. 70% of them were for generic drugs. CMS names the drug for 834 of them, across 34 drugs with 11 or more claims each, at $1,834,037 in total drug cost. In 2023, CMS named 803 claims across 26 drugs.

Dr. Ibrahim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ibrahim as offering telehealth.

Dmand AI links 11 papers to Dr. Ibrahim, published from 2012 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Ethiopia, Cattle and Malaria. Dr. Ibrahim's most frequent co-authors are Joseph Decristofaro, MD, Danny Liaw, MD and Echezona Maduekwe, MD.

CMS Open Payments shows 402 general payments to Dr. Ibrahim from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,831.